Vanderbilt University Medical Center becomes the first site to enroll a participant in the Antibody Mediated Prevention (AMP) study. The AMP study, supported by the NIH, is a randomized controlled trial testing the infection-preventing ability of a monoclonal antibody VRCO1 against HIV.
Read more »